Pharmaceutical Technology

JUNE 15, 2023

Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S. While this process is essential, it’s also slow, expensive and unpredictable.

Drug Development 52

Drug Development Compounding Adverse Reactions Dosage 52

Pharmaceutical Technology

MAY 31, 2023

The university and Pharos have drawn up a memorandum of understanding (MoU) to use AI technology to identify potential compounds for the rapid development of treatments. The MoU allows Pharos to collaborate with the university’s researchers and gives access to its advanced drug discovery infrastructure.

Compounding 59

Compounding Data Entry Drug Development Pharmaceutical Companies 59

pharmaphorum

JULY 21, 2021

In 2019, a team at Massachusetts Institute of Technology (MIT) in the US came up with just such a model, and found that it was able to perform “better than random” at predicting the outcome of a clinical trial or development programme.

Data Entry 104

Data Entry Drug Development Compounding 104

pharmaphorum

SEPTEMBER 11, 2020

As the amount and types of data expand exponentially, this problem only intensifies. Yet, ironically, that very growth in data sources may be one reason solutions have been slow to take hold. Clearing redundant data then becomes difficult, and programming complex edit checks becomes impossible.

Data Entry 70

Data Entry Documentation Drug Development 70

European Pharmaceutical Review

MARCH 12, 2024

Data integrity is the term used to describe the accuracy, consistency and reliability of data throughout its lifecycle. In the pharmaceutical/life sciences industries, maintaining data integrity is crucial given its role in making critical decisions that shape outcomes from drug development to human health.

Documentation 90

Documentation Data Entry Communication Compounding 90

pharmaphorum

SEPTEMBER 6, 2021

Many practitioners have expressed the feeling that EHRs cause far too much of their time ultimately being spent on data entry. This comes from a variety of issues linked to these systems, but there is a big one of note. Finally, there is now a compelling reason for blockchain’s implementation in life sciences, here’s why.

Medical Records 137

Medical Records Health and Personal Care Stores Data Entry Hospitals 137

pharmaphorum

DECEMBER 6, 2022

Iddo Peleg (CEO, and one of the four co-founders of YonaLink) and Gav Martell (co-founder and vice president of business development) discussed how a recent $6 million funding round led by Debiopharm Innovation Fund will support their mission to transform clinical trials and bring lifesaving therapies to market faster.

Data Entry 98

Data Entry Communication Hospitals Documentation 98